The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS
Article 2003 en
Authors
MI
Matilde Inglese
JW
J.H.T.M. van Waesberghe
MR
Marco Rovaris
Abstract
1 min read
In this cohort of patients with secondary progressive MS, interferon beta-1b did not show an overall effect on the worsening of magnetization transfer MRI measures, when compared with placebo. The data show that change in magnetization transfer ratio is a promising tool for monitoring disease evolution in secondary progressive MS and that the information obtained from magnetization transfer MRI complements that obtained from MRI measures of lesion load and inflammation.
P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller
P. D. Molyneux, Gareth J. Barker, Frederik Barkhof, K. Beckmann, Frank Dahlke, Massimo Filippi, Mahdiyeh Khabbaz Koche Ghazi, David W. Hahn, Deirdre MacManus, Chris H. Polman, Carlo Pozzilli, Ludwig Kappos, Alan J. Thompson, Klaus Wagner, Tarek Yousry, D. H. Miller
Hans-Peter Hartung, Ludwig Kappos, Douglas S. Goodin, Paul O’Connor, Massimo Filippi, Barry G.W. Arnason, Giancarlo Comi, Stuart D. Cook, Douglas Jeffery, John Petkau, Richard White, Timon Bogumil, K. Beckmann, Brigitte Stemper, Gustavo Cruz, Rupert Sandbrink, Christoph Pohl
Kathryn C. Fitzgerald, Kassandra L. Munger, Karl Köchert, Barry G.W. Arnason, Gıancarlo Comı, Stuart D. Cook, Douglas S. Goodin, Massimo Filippi, Hans-Peter Hartung, Douglas Jeffery, Paul O’Connor, Gustavo Cruz, Rupert Sandbrink, Ludwig Kappos, Christoph Pohl, Alberto Ascherio
Discussion(0)
No comments yet. Be the first to comment.